Efficacy and safety of tipepidine as adjunctive therapy in major depressive disorder: A randomized, double‐blind, placebo‐controlled clinical trial-Reference-Cited by-同舟云学术

Efficacy and safety of tipepidine as adjunctive therapy in major depressive disorder: A randomized, double‐blind, placebo‐controlled clinical trial

Published:2020-12-19 Issue:2 Volume:75 Page:57-62
ISSN:1323-1316
Container-title:Psychiatry and Clinical Neurosciences
language:en
Short-container-title:Psychiatry Clin. Neurosci.

Author:

Hoobehfekr Saba¹,Moghaddam Hossein Sanjari¹,Shalbafan Mohammadreza²,Hashemi Maryam Ghazizadeh²,Pirmoradi Mohammad Mehdi¹,Sakenian Amirhossein¹,Poopak Amirhossein¹,Kashefinejad Shayan²,Yarahmadi Masoomeh³,Akhondzadeh Shahin¹^ORCID

Affiliation:

1. Psychiatric Research Center, Roozbeh Hospital Tehran University of Medical Sciences Tehran Iran

2. Mental Health Research Center, Department of Psychiatry, School of Medicine Iran University of Medical Sciences Tehran Iran

3. Department of Health Psychology, Khorramshahr – Persian Gulf International Branch Islamic Azad University Khorramshahr Iran

Funder

Tehran University of Medical Sciences and Health Services

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Neurology,Neurology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pcn.13180

Reference56 articles.

1. A 40-Year Perspective on the Prevalence of Depression

2. Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication

3. Risk factors for suicide in later life

4. Anxiety, Depression, and Quality of Life in Primary Care Patients

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of combination effect of quinidine on the pharmacokinetics of tipepidine using a physiologically based pharmacokinetic model;Xenobiotica;2024-01-17

2. Brain-based Sex Differences in Depression: A Systematic Review of Neuroimaging Studies;Brain Imaging and Behavior;2023-04-14

3. Estimation of contribution of CYP2D6 to tipepidine metabolism in humans and prolongation of the half-life of tipepidine by combination use with a CYP2D6 inhibitor in chimeric mice with humanised liver;Xenobiotica;2023-04-03